CommentaryClinical Trials Accrual to Cancer Clinical Trials in the Era of Molecular Medicine Richard L. SchilskySection of Hematology-Oncology and Comprehensive Cancer Center, University of Chicago, Chicago, IL 60637, USA.E-mail: rschilsk{at}medicine.bsd.uchicago.edu See allHide authors and affiliations Science Translational Medicine 23 Mar 2011:Vol. 3, Issue 75, pp. 75cm9DOI: 10.1126/scitranslmed.3001712 Richard L. Schilsky Find this author on Google Scholar Find this author on PubMed Search for this author on this site Article Figures & Data Info & Metrics eLetters PDF Article Information vol. 3 no. 75 75cm9 DOI: https://doi.org/10.1126/scitranslmed.3001712 PubMed: 21430267 Published By: American Association for the Advancement of Science Print ISSN: 1946-6234 Online ISSN: 1946-6242 History: . Copyright & Usage: Copyright © 2011, American Association for the Advancement of Science Author Information Richard L. SchilskySection of Hematology-Oncology and Comprehensive Cancer Center, University of Chicago, Chicago, IL 60637, USA.E-mail: rschilsk{at}medicine.bsd.uchicago.edu Altmetric Article usage Article lifetimeLast 6 monthsThis monthArticle usage: March 2011 to January 2021 AbstractFullPdf Mar 20111613375181 Apr 201158710960 May 20112331230 Jun 2011332424 Jul 20112872621 Aug 20111623527 Sep 20111666253 Oct 20111143813 Nov 2011983722 Dec 2011812118 Jan 2012752014 Feb 2012883123 Mar 2012764515 Apr 20121033316 May 2012622024 Jun 2012611511 Jul 2012531711 Aug 2012762616 Sep 2012471216 Oct 201254116 Nov 201244107 Dec 2012772520 Jan 2013733411 Feb 20135556 Mar 201384227 Apr 20131292519 May 2013811813 Jun 2013792611 Jul 20133074 Aug 20133774 Sep 20133283 Oct 2013631114 Nov 20132788 Dec 20132185 Jan 2014371216 Feb 2014381216 Mar 2014491211 Apr 2014481310 May 201438219 Jun 20142594 Jul 201425911 Aug 2014301214 Sep 20141467 Oct 201436157 Nov 2014191413 Dec 201416610 Jan 2015211928 Feb 20151652 Mar 20151913 Apr 20154668 May 20152176 Jun 20151893 Jul 201522201 Aug 20153668 Sep 20152955 Oct 201518114 Nov 20153651 Dec 201526112 Jan 20163378 Feb 201629420 Mar 201640713 Apr 20161845 May 201653915 Jun 20162999 Jul 201622711 Aug 201618714 Sep 20162594 Oct 20161859 Nov 201630124 Dec 2016291623 Jan 2017121336 Feb 2017241128 Mar 201723921 Apr 2017211023 May 2017341836 Jun 2017141115 Jul 2017241316 Aug 2017432317 Sep 201724257 Oct 2017301612 Nov 2017322616 Dec 2017311820 Jan 2018311431 Feb 201828812 Mar 2018161215 Apr 2018291212 May 2018403117 Jun 2018433326 Jul 2018101718 Aug 20180316 Sep 201807828 Oct 201818739 Nov 201826112 Dec 201848124 Jan 201945821 Feb 2019106916 Mar 201942812 Apr 201972013 May 20194267 Jun 20196213 Jul 20194209 Aug 20194178 Sep 20193134 Oct 201951710 Nov 2019365 Dec 20196136 Jan 20203137 Feb 20205105 Mar 20204114 Apr 2020294 May 20202112 Jun 20201408 Jul 20202341 Aug 2020177 Sep 20204306 Oct 20205438 Nov 20201159 Dec 202032512 Jan 2021236 View Full Text
Accrual to Cancer Clinical Trials in the Era of Molecular Medicine By Richard L. Schilsky Science Translational Medicine23 Mar 2011 : 75cm9 In the testing of targeted cancer therapies, new issues can complicate the decision by patients or providers to participate in clinical trials.
Accrual to Cancer Clinical Trials in the Era of Molecular Medicine By Richard L. Schilsky Science Translational Medicine23 Mar 2011 : 75cm9 In the testing of targeted cancer therapies, new issues can complicate the decision by patients or providers to participate in clinical trials.